Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Biogen Inc. (BIIB)

-NasdaqGS
318.78 Up 1.78(0.56%) Jul 31, 4:00PM EDT
|After Hours : 318.50 Down 0.28 (0.09%) Jul 31, 7:51PM EDT
Add to Portfolio
Prev Close:317.00
Open:319.57
Bid:305.00 x 100
Ask:322.10 x 100
1y Target Est:387.93
Beta:0.5
Earnings Date:Oct 20 - Oct 26 (Est.)
Day's Range:312.70 - 322.35
52wk Range:290.85 - 480.18
Volume:2,261,458
Avg Vol (3m):1,917,070
Market Cap:74.97B
P/E (ttm):21.59
EPS (ttm):14.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.56%74.97B
PFEUp 0.92%222.05B

Key Statistics

Forward P/E (1 yr):18.00
P/S (ttm):7.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :15.92
Quarterly EPS Est (Sep-15) :3.92
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback